There is 1 paper on IL-13 in aging research: none in people yet, 1 in animals.
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
Cells: a single group. Worms or flies, mice and humans: nothing yet.
- 1 lab in 1 country
- Funders: National Natural Science Foundation of China and 3 more
- Animals1
Effects
1NAD+ metabolism
upin mouse cells1
1 study
NAD+ metabolism
upin mouse cells1
IL-13 activates NAD+ metabolism in mouse cells (via Trem2 binding and the Syk-Sp1-SLC25A51 pathway).
“interleukin (IL)-13 from senescent macrophages directly bound Trem2, activating the Syk-Sp1-SLC25A51 pathway to enhance mitochondrial nicotinamide adenine dinucleotide (NAD)+ transport”
Cellsvia Trem2 binding and the Syk-Sp1-SLC25A51 pathway
Molecular biomedicine
Latest
1 paper in 12 monthsMolecular Biomedicine
Macrophage Trem2 deficiency aggravates aging-induced vascular remodeling by acting as a non-classical receptor of interleukin-13
Experiments in miceTREM2